Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Mirkin

Showing results (51-60 of 104) with videos related to

Pageof 11
Sort By:
Maturitas|April 4, 2015
17β-Estradiol and natural progesterone for menopausal hormone therapy: REPLENISH phase 3 study design of a combination capsule and evidence reviewSebastian Mirkin, Julia M Amadio, Brian A Bernick, et al.
Menopause (New York, N.Y.)|August 26, 2020
Breast effects of oral, combined 17β-estradiol, and progesterone capsules in menopausal women: a randomized controlled trialJames H Liu, Denise R Black, Lisa Larkin, et al.
Pharmacy (Basel, Switzerland)|September 3, 2020
Long-Lasting, Patient-Controlled, Procedure-Free Contraception: A Review of Annovera with a Pharmacist PerspectiveJennifer J Virro, Kathleen Besinque, Christiane E Carney, et al.
Menopause (New York, N.Y.)|February 3, 2016
A randomized, double-blind, placebo-controlled phase 2 pilot trial evaluating a novel, vaginal softgel capsule containing solubilized estradiolJames H Pickar, Julia M Amadio, John M Hill, et al.
Journal of Assisted Reproduction and Genetics|December 3, 2003
Factors associated with an optimal pregnancy outcome in an oocyte donation programSebastian Mirkin, Trinidad Garcia Gimeno, Carmina Bovea, et al.
Menopause (New York, N.Y.)|November 30, 2018
Oral 17β-estradiol/progesterone (TX-001HR) and quality of life in postmenopausal women with vasomotor symptomsJames A Simon, Andrew M Kaunitz, Robin Kroll, et al.
Menopause (New York, N.Y.)|February 13, 2014
Differential effects of menopausal therapies on the endometriumSebastian Mirkin, David F Archer, Hugh S Taylor, et al.
Journal of Assisted Reproduction and Genetics|September 2, 2003
Impact of transabdominal ultrasound guidance on performance and outcome of transcervical uterine embryo transferSebastian Mirkin, Estella L Jones, Jacob F Mayer, et al.
Menopause (New York, N.Y.)|January 3, 2019
Relationship between vasomotor symptom improvements and quality of life and sleep outcomes in menopausal women treated with oral, combined 17β-estradiol/progesteroneSebastian Mirkin, Shelli Graham, Dennis A Revicki, et al.
Menopause (New York, N.Y.)|March 20, 2019
Endometrial safety of low-dose vaginal estrogens in menopausal women: a systematic evidence reviewGinger D Constantine, Shelli Graham, Kate Lapane, et al.
Pageof 11

Showing results (51-60 of 104) with videos related to

Sort By:
Pageof 11
Maturitas|April 4, 2015
17β-Estradiol and natural progesterone for menopausal hormone therapy: REPLENISH phase 3 study design of a combination capsule and evidence reviewSebastian Mirkin, Julia M Amadio, Brian A Bernick, et al.
Menopause (New York, N.Y.)|August 26, 2020
Breast effects of oral, combined 17β-estradiol, and progesterone capsules in menopausal women: a randomized controlled trialJames H Liu, Denise R Black, Lisa Larkin, et al.
Pharmacy (Basel, Switzerland)|September 3, 2020
Long-Lasting, Patient-Controlled, Procedure-Free Contraception: A Review of Annovera with a Pharmacist PerspectiveJennifer J Virro, Kathleen Besinque, Christiane E Carney, et al.
Menopause (New York, N.Y.)|February 3, 2016
A randomized, double-blind, placebo-controlled phase 2 pilot trial evaluating a novel, vaginal softgel capsule containing solubilized estradiolJames H Pickar, Julia M Amadio, John M Hill, et al.
Journal of Assisted Reproduction and Genetics|December 3, 2003
Factors associated with an optimal pregnancy outcome in an oocyte donation programSebastian Mirkin, Trinidad Garcia Gimeno, Carmina Bovea, et al.
Menopause (New York, N.Y.)|November 30, 2018
Oral 17β-estradiol/progesterone (TX-001HR) and quality of life in postmenopausal women with vasomotor symptomsJames A Simon, Andrew M Kaunitz, Robin Kroll, et al.
Menopause (New York, N.Y.)|February 13, 2014
Differential effects of menopausal therapies on the endometriumSebastian Mirkin, David F Archer, Hugh S Taylor, et al.
Journal of Assisted Reproduction and Genetics|September 2, 2003
Impact of transabdominal ultrasound guidance on performance and outcome of transcervical uterine embryo transferSebastian Mirkin, Estella L Jones, Jacob F Mayer, et al.
Menopause (New York, N.Y.)|January 3, 2019
Relationship between vasomotor symptom improvements and quality of life and sleep outcomes in menopausal women treated with oral, combined 17β-estradiol/progesteroneSebastian Mirkin, Shelli Graham, Dennis A Revicki, et al.
Menopause (New York, N.Y.)|March 20, 2019
Endometrial safety of low-dose vaginal estrogens in menopausal women: a systematic evidence reviewGinger D Constantine, Shelli Graham, Kate Lapane, et al.
Pageof 11